REFERENCES
- Beeh KM, Wagner F, Khindri S, Effect of Indacaterol on Dynamic Lung Hyperinflation and Breathlessness in Hyperinflated Patients with COPD. COPD 2011; July 17.
- O'Donnell, DE. Casaburi R, Vincken, W, Effect of Indacaterol on Exercise Endurance and Lung Hyperinflation in COPD. Respiratory Medicine 2011; 105(7):1030–6.
- Dahl, R, Chung KF, Buhl R, Efficacy of a New Once-Daily Long-Acting Inhaled Beta 2 –Agonist Indacaterol versus Twice-Daily Formoterol in COPD. Thorax 2010; 65(6):473–9.
- Kornmann,O, Dahl E, Centanni S, Once-Daily Indacaterol versus Twice-Daily Salmeterol for COPD: a Placebo-Controlled Comparison. Eur Respir J 2011; 37(2):273–9.
- Cazzola M, MacNee W, Martinez FJ, Outcomes for COPD Pharmacological Trials: From Lung Function to Biomarkers. Eur Respir J 2008; 31(2):416–69.
- US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). NDA 22-383 Briefing Document. At: http://www.fda. gov/downloads/AdvisoryCommittees/CommitteesMeetingMat- erials/Drugs/Pulmonary-AllerfgyDrugsAdvisoryCommittee/ UCM245639.pdf [accessed 8 June 2011].
- Donohue JF, Fogarty C. Lotvall C, Once-Daily Bronchodilators for Chronic Obstructive Pulmonary Disease: Indacaterol versus Tiotropium. Am J Respir Crit Care Med 2010; 182:155–162.
- Barnes PJ, Pocock SJ, Magnussen H, Integrating indacaterol dose selection in a clinical study in COPD using an adaptive seamless design. Pulm Pharmacol Ther. 2010 Jun; 23(3):165–71. Epub 2010 Jan 18.
- Renard D, Looby M, Kramer B, Characterization of the Bronchodilatory Dose Response to Indacaterol in Patients with Chronic Obstructive Pulmonary Disease using Model-Based Approaches. Respir Res. 2011 April 26; 12:54.
- Toy EL, Beaulieu NU, McHale JM, Treatment of COPD: Relationships between Daily Dosing Frequency, Adherence, Resource Use and Costs. Respir Med 2011 Mar; 105(3):435–41.
- Wang J, Nie B, Xiong W, Effect of Long Acting Beta Agonists on the Frequency of COPD Exacerbations: A Meta-Analysis. J Clin Pharm Ther. 2011 Jul 11. doi: 10.1111/j.1365-2710.2011.01285.x.
- Buhl R, Dunn LJ, Disdier C, Blinded 12 week Comparison of Once-Daily Indacaterol and Tiotropium in COPD. Eur Respir J 2011, May 26.
- Donohue JF, Singh D, Kornmann O, Safety of Indacaterol in the Treatment of Patients with COPD International J of COPD. 2011; accepted.